FAIRMOUNT FUNDS MANAGEMENT LLC sold 56.0% of their position (7M shares) of COGENT BIOSCIENCES, INC. on the open market
Open‑market sale worth $242.62M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/31/2026ACC: 0001104659-26-038057
10% Owner
Since Jul 2020
-28K
Net shares
Net seller
$242.62M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7M acquired · 7.03M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+7M
Price / share
—
Trade value
—
% of position
127.2%
3/31/2026
5.50M→12.50M
Common Stock
Indirect
Shares
−7M
Price / share
$34.66
Trade value
$242.62M
% of position
56.0%
3/31/2026
12.50M→5.50M
Total
Net shares
+0.00
Net value
-$242.62M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/31/2026 | C · Conversion | +7M | — | — | 127.2% | 5.50M | 12.50M |
| Common Stock Indirect | 3/31/2026 | S · Sale | −7M | $34.66 | $242.62M | 56.0% | 12.50M | 5.50M |
| Total | +0.00 | -$242.62M | ||||||
Derivative Transactions1
Series A Convertible Preferred Stock
Indirect
Converts to
Common Stock
7M shares
Shares
−28K
Strike price
Held after
39.41K
Exercisable
—
3/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Indirect | Common Stock7M shares | 3/31/2026 | C · Conversion | −28K | — | 39.41K |